Esperion Therapeutics reported $8.85M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Amarin AMRN:US $ 111.83M 10.51M
Amgen AMGN:US $ 5097M 208M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Daiichi Sankyo 4568:JP Y 178489M 428M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Flexion Therapeutics FLXN:US $ 17.6M 5.6M
Halozyme Therapeutics HALO:US $ 97.24M 16.2M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Intra Cellular Therapies ITCI:US $ 20.21M 2.2M
IONIS PHARMACEUT IONS:US $ 130M 7.21M
Merk MRK:US $ 10098M 1738M
Moderna Inc MRNA:US 4.25B 643M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Pfizer PFE:US $ 14163M 2178M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Puma Biotechnology PBYI:US $ 35.97M 5.45M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Seattle Genetics SGEN:US $ 341.41M 31.02M
United Therapeutics UTHR:US $ 417M 7.7M
Vanda Pharmaceuticals VNDA:US $ 63.3M 1.96M
Zogenix ZGNX:US $ 21.32M 3.75M